As an example, the overexpression of miR-31 and miR-146a, both of which target CD40L (predicted or experimentally confirmed), in the matched samples suggests that the CD40:CD40L costimulatory pathway plays an important role in promoting localized inflammation; CD40 and CD40L are elevated in IBD [52]. Here, CD40LG is linked to inflammatory bowel disease.